FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/07/043645 [Registered on: 01/07/2022] Trial Registered Prospectively
Last Modified On: 29/06/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to evaluate the efficacy of Aragwadha Pushpa Lepa in the management of Vyanga with special reference to Melasma 
Scientific Title of Study   A randomized controlled clinical study to evaluate the efficacy of Aragwadha Pushpa Lepa (Cassia fistula Linn.) in the management of Vyanga with special reference to Melasma 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nanditha M 
Designation  MD Student 
Affiliation  Sri Sri College of Ayurvedic Science and Research 
Address  2nd year PG scholar, Department of Dravyaguna, Sri Sri College of Ayurvedic Science and Research, Kanakapura road, Bangalore

Bangalore
KARNATAKA
560082
India 
Phone  9036345368  
Fax    
Email  nandithabhavana@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mahesh C D 
Designation  Guide & Professor 
Affiliation  Sri Sri College of Ayurvedic Science and Research 
Address  Professor, Department of Dravyaguna, Sri Sri College of Ayurvedic Science and Research, Kanakapura road, Bangalore

Bangalore
KARNATAKA
560082
India 
Phone  8073119372  
Fax    
Email  drmaheshcd@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Nanditha M 
Designation  MD Student 
Affiliation  Sri Sri College of Ayurvedic Science and Research 
Address  2nd year PG scholar, Department of Dravyaguna, Sri Sri College of Ayurvedic Science and Research, Kanakapura road, Bangalore

Bangalore
KARNATAKA
560082
India 
Phone  9036345368  
Fax    
Email  nandithabhavana@gmail.com  
 
Source of Monetary or Material Support  
Sri Sri College of Ayurvedic Science and Research Hospital, Bangalore 
 
Primary Sponsor  
Name  Sri Sri College of Ayurvedic Science and Research Hospital 
Address  Sri Sri College of Ayurvedic Science and Research Hospital, Kanakapura road, Bangalore 560082 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nanditha M  Sri Sri College of Ayurvedic Science and Research Hospital  Department of KC 3, Sri Sri College of Ayurvedic Science and Research Hospital, Kanakapura road, Bangalore
Bangalore
KARNATAKA 
9036345368

nandithabhavana@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri Sri Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L811||Chloasma. Ayurveda Condition: VYANGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Aragvadha Pushpa, Reference: NA, Route: Topical, Dosage Form: Kalka/ Paste, Dose: 5(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -Folklore reference
2Comparator ArmDrugClassical(1) Medicine Name: Varnya Dashemani, Reference: Charaka Samhita, Sutra Sthana, 4th chapter, Route: Topical, Dosage Form: Kalka/ Paste , Dose: 5(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Subjects fulfilling the diagnostic criteria of Vyanga with special reference to Melasma will be randomly selected, irrespective of their religion, occupation and socio-economic status 
 
ExclusionCriteria 
Details  1) Female on oral contraceptive pills, pregnant women and lactating women
2) Who are on any hormonal therapy
3) Known hyperpigmentation since birth
4) Known inflammatory pigmentation
5) Known malignant melanoma
6) Any other condition interfering with the course of the treatment
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improved uniformity in colour of facial skin  30 days 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in number of hyper pigmented lesions over facial skin  30 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   04/07/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized, open label, parallel group, active controlled trail comparing the efficacy of Aragwadha Pushpa Lepa and Varnya Dashemani Lepa for 30 days in 30 patients with Vyanga (Melasma) that will be conducted at Sri Sri College of Ayurvedic Science and Research, Kanakapura road, Bangalore. Both subjective and objective criteria are used for assessment in the study. This study might reduce the necessity of usage of 10 drugs to using 1 drug in the condition of Vyanga (Melasma). 
Close